Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Stevanato Group SpA's Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was MXN4,186 Mil. Therefore, Stevanato Group SpA's EV-to-EBIT ratio for today is 24.17.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Stevanato Group SpA's Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was MXN5,173 Mil. Therefore, Stevanato Group SpA's EV-to-EBITDA ratio for today is 19.55.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Stevanato Group SpA's Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was MXN25,607 Mil. Therefore, Stevanato Group SpA's EV-to-Revenue ratio for today is 3.95.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Stevanato Group SpA (MEX:STVN N) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN4,186 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,173 Mil.
Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN25,607 Mil.
Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,215 Mil.
Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil.
Stevanato Group SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-617 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stevanato Group SpA Enterprise Value Related Terms
Stevanato Group SpA Enterprise Value Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:STVN N vs MMED, TFX, MMSI: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Stevanato Group SpA's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of MXN101,160 Mil mean?
Stevanato Group SpA (MEX:STVN N) has a Enterprise Value of MXN101,160 Mil as of Sep. 09, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Stevanato Group SpA and its competitors.
Is Stevanato Group SpA's Enterprise Value too high?
Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil. Overall, Stevanato Group SpA has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Enterprise Value compare to MMED and TFX?
Stevanato Group SpA's Enterprise Value of MXN101,160 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Stevanato Group SpA and its competitors. Stevanato Group SpA's current Enterprise Value is MXN101,160 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Stevanato Group SpA (MEX:STVN N) has a current Enterprise Value of MXN101,160 Mil. The stock's GF Value™ is MXN315.25, compared to a current price of MXN246.00 — trading 22% below its estimated fair value. The current Enterprise Value is MXN101,160 Mil. Stevanato Group SpA's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Stevanato Group SpA (MEX:STVN N), the current Enterprise Value is MXN101,160 Mil as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (MEX:STVN N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of MXN246.00 is trading 22% below its estimated GF Value™ of MXN315.25.
Key valuation signals for MEX:STVN N:
Enterprise Value: MXN101,160 Mil
GF Value™: MXN315.25 vs. price of MXN246.00 (22% below fair value)
No single metric tells the full story. See the MEX:STVN N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
87GF Score
Get the complete analysis for MEX:STVN N
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:STVN N has been successfully added to your 
